Fingosol 0,5 0,5 mg Capsule
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of relapsing forms of multiple sclerosis.
Dosage (summary)
1 capsule (0.5 mg) orally once daily.
Onset of Action / Duration
Onset: 1 hour, Duration: 6-8 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
- Diabetic patients
Pregnancy & Breastfeeding
Not recommended in pregnancy or lactation.
Key Drug Interactions
- Beta blockers
- Class Ia and III antidysrhythmics
- CYP450 inducers
Contraindications
- Hypersensitivity
- Severe hepatic impairment
- Severe cardiac dysrhythmias
- Immunodeficiency syndrome
Common side effects
- Bradycardia
- Headache
- Dizziness
- Infections
- Increased hepatic enzymes
Counselling Points
- Monitor for signs of infection
- Regular liver function tests
- Avoid live vaccines
Serious warnings
- Risk of bradycardia
- Increased risk of infections
- Potential for PML
Important Disclaimer
The Fingosol 0,5 0,5 mg Capsule professional information leaflet below is the property of Cipla Medpro (Pty)Ltd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
